Table 3.
Comparison of cytokine levels in relation to epidemiological variables among patients with acute COVID-19.
| Variables | IL-17 (pg/mL) Median (IIQ) | IFN-γ (pg/mL) Median (IIQ) | TNF-α (pg/mL) Median (IIQ) | IL-10 (pg/mL) Median (IIQ) | IL-6 (pg/mL) Median (IIQ) | IL-4 (pg/mL) Median (IIQ) | IL-2 (pg/mL) Median (IIQ) |
|---|---|---|---|---|---|---|---|
| Sex* | |||||||
| Female | 15.44 (17.66) | 8.21 (3.71) | 6.00 (3.50) | 8.96 (3.82) | 12.56 (8.84) | 9.43 (7.02) | 6.76 (2.03) |
| Male | 15.45 (11.58) | 8.24 (3.67) | 6.25 (3.28) | 9.95 (3.25) | 11.70 (7.90) | 8.09 (4.75) | 6.96 (1.80) |
| p | 0.9735 | 0.7270 | 0.7688 | 0.1618 | 0.8733 | 0.2121 | 0.3360 |
| Age (years)** | |||||||
| 21-40 | 15.80 (9.30) | 8.37 (3.09) | 7.67 (3.94) | 8.56 (2.32) | 11.39 (4.27) | 10.34 (4.82) | 7.44 (2.10) |
| 41-60 | 15.31 (16.76) | 8.35 (3.29) | 6.78 (2.94) | 9.59 (3.50) | 12.71 (9.24) | 8.46 (5.26) | 6.88 (1.95) |
| >60 | 11.74 (16.76) | 8.05 (3.05) | 5.95 (3.14) | 10.43 (2.80) | 14.51 (11.97) | 7.86 (5.17) | 5.52 (1.77) |
| p | 0.6310 | 0.9853 | 0.0257 | 0.1674 | 0.0636 | 0.2700 | 0.1263 |
| Comorbidities * | |||||||
| Yes | 16.40 (17.03) | 7.70 (2.87) | 5.69 (2.33) | 9.63 (4.67) | 13.13 (11.68) | 7.27 (4.88) | 6.61 (1.73) |
| No | 15.45 (9.30) | 8.65 (3.02) | 7.05 (3.59) | 9.39 (3.08) | 11.35 (4.96) | 10.19 (4.84) | 7.49 (1.68) |
| p | 0.9922 | 0.2527 | 0.0030 | 0.9893 | 0.0891 | 0.0020 | 0.0021 |
IIQ, interquartile range; * Mann–Whitney test; ** Kruskal–Wallis test.